Leading Taiwan-based contract development and manufacturing organization (CDMO) 
Bora Group today announced a name change for its subsidiary, currently Yuta 
Health, to Bora Health Inc. as part of an overall plan to integrate its 
distribution operations and brands. With the name change, Bora plans to 
complete the merging of the operations of Bora Health and Union Chemical & 
Pharmaceutical by the end of 2021. In the future, Bora's two main businesses, 
CDMO and distribution services, will integrate brand resources and focus on the 
global development of their respective manufacturing and sales businesses in 
order to create greater value and benefits. 

Bora's executives have reiterated that the group remains committed to driving 
the success of its pharmaceutical customers in the global market. This will be 
achieved by strengthening the group's capabilities in drug development and 
manufacturing services in tandem with expanding its presence across the global 
pharmaceutical supply chain ecosystem, while leveraging its high-quality drug 
distribution services to seek new opportunities in the domestic drug and 
healthcare product markets. Specifically, Bora Health will continue to focus on 
the consumer healthcare market while Union Chemical & Pharmaceutical will 
specialize in prescription drugs. Bora's continued accelerated growth has made 
brand reorganization an essential part of its long-term development strategy. 
With the organizational restructuring, Bora aims to integrate and expand its 
distribution and marketing services with a focus on prescription and OTC drugs 
and consumer healthcare products in a move to further its growth while creating 
more social and economic benefits through its brands. 

Bora also disclosed that group chairman Bobby Sheng will lead Bora Health as 
chairman. The move to have the CDMO and distribution businesses each operate 
independently will further boost their growth in the markets they are engaged 
in. Additionally, by leveraging Bora's strong brand awareness and competitive 
CDMO services, Bora Health expects to enhance its distribution capabilities in 
world markets and deliver added value backed by brand consistency.

SOURCE Bora corp